Showing results (1871-1880 of 2,369) with videos related to

Sort By:
Pageof 237
European Urology|December 31, 2011
Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sampleQuoc-Dien Trinh, Jesse Sammon, Maxine Sun, et al.
European Radiology|February 14, 2020
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1Giorgio Brembilla, Paolo Dell'Oglio, Armando Stabile, et al.
European Urology Focus|March 3, 2021
Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific ValidationLuigi Nocera, Claudia Collà Ruvolo, Lara F Stolzenbach, et al.
European Urology Oncology|June 16, 2019
Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 TrialsMarco Bandini, Alberto Briganti, Elizabeth R Plimack, et al.
European Urology|January 6, 2024
Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder CancerFilippo Pederzoli, Michela Riba, Chiara Venegoni, et al.
ESMO Open|April 22, 2026
Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence studyA Cigliola, B A Maiorano, F Rossari, et al.
BJU International|April 23, 2026
Iatrogenic ureteric injuries after abdominal surgery: a systematic review and meta-regression from the European Association of Urology Endourology SectionPietro Scilipoti, Nicola Nannola, Federico Zorzi, et al.
Journal of Clinical Medicine|November 9, 2024
Surgery or Comorbidities: What Is the Primum Movens of Kidney Dysfunction After Nephrectomy? A Multicenter Study in Living Donors and Cancer PatientsFrancesco Trevisani, Matteo Floris, Francesco Trepiccione, et al.
The Prostate|October 28, 2024
Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohortsMarco Finati, Chase Morrison, Alex Stephens, et al.
Frontiers in Oncology|December 23, 2022
Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerationsLuigi Nocera, Lara F Stolzenbach, Claudia Collà Ruvolo, et al.
Pageof 237